Articles

Alcon launched its AcrySof IQ ReSTOR Multifocal Toric intraocular lens (IOL) during the 2010 European Society of Cataract and Refractive Surgeons (ESCRS) annual meeting in Paris, France.

Breaking news from the floor of ESCRS

Breaking news from the floor of ESCRS

Breaking news from the floor of ESCRS

Breaking news from the floor of ESCRS

Breaking news from the floor of ESCRS

Helping others to help themselves

Understanding the problems of contact lens induced dry eye

Five steps and the criteria for success, as seen through the eyes of patients and their doctors...

Ellex Medical Lasers has reported a 16% increase in profits for the year ended 30 June 2010.

The femtosecond cataract laser introduces a level of safety, efficacy and reproducibility that will benefit all cataract surgeons, according to Dr Zoltan Nagy of Hungary.

A Swedish team has successfully implanted biosynthetic corneas in a small human trial, in a clinical study first.

Novartis and Nestlé have completed the purchase of around 156 million Alcon shares for a staggering $28.3 billion in cash, giving Novartis control of approximately 77% of Alcon?s outstanding shares.

According to a recent report there may be as many as a million children with an undetected vision defect due to around 70% of schools not providing eye screening.

Thomas G. Frinzi is to become company President and Chief Executive Officer at WaveTec Vision. He replaces Tom Berryman who after a period of transition will be leaving the company to pursue other entrepreneurial ventures.

Alcon, Inc. has received regulatory approval for its acquisition of LenSx Lasers, Inc.

A new study has found that for primary open-angle glaucoma (POAG) a higher body weight in women, in particular body mass index BMI, is not associated with higher risk of the disease.

A clinical study, published recently in Eye journal, looked at the relationship between the cornea and the optic disc and suggests that there is a structural relationship between the two

The newly released EyeSuite biometry software for the LENSTAR LS 900 optical biometer provides the user with complete biometry of the entire eye, including lens thickness and also allows direct connection and use of this valuable data with the most advanced IOL calculation tools.

The European Society of Ophthalmology (SOE) and the American Academy of Ophthalmology (AAO) will be holding their joint Congress in Geneva, Switzerland on 4-7 June 2011.

This question was posed by Irv Arons who said: “In reviewing an article about proposed new uses for the femtosecond laser, I came across a term that I had not heard of before ? laser photolysis.....

OptiMedica Corp., has sold its retina and glaucoma business to Topcon Corp., leaving it in a strong position to invest in the launch of its laser cataract surgery system as well as continued cataract-focused research and development.

Dr Yeni H. Yucel, an ophthalmic pathologist at St. Michael's Hospital, has won the prestigious 2010 Lewis Rudin Glaucoma Prize from the New York Academy of Medicine.

The establishment of an operating theatre in León/Nicaragua will provide ophthalmologists and students with new training facilities which will lead to im-proved treatment for patients.

RaySert is a small-incision IOL injector system with a 1.8 mm diameter external tip, designed to enable surgeons to insert an IOL through a sub 2.5 mm incision, to reduce induced astigmatism.

Thanks to all those readers, cataract and refractive surgeons who completed our recent survey about the choices you make on behalf of your patients.

An interesting, but controversial, method to eliminate bothersome floaters.

In a recent blog Dr Mark Packer said: “Somewhere in the back of my mind I keep a quote about perseverance and simplicity. It comes from an interview with Ernest Hemingway. The author was asked to explain why he rewrote the last page of A Farewell to Arms 39 times.”

Get the most out of your stay in Paris by looking out for OTEurope?s City Guide. We recommend the best restaurants, bars and cafés to visit and the sights not to be missed.

Researchers at the University of Massachusetts Medical School (UMMS) believe they may have found a new treatment for retinitis pigmentosa (RP), a severe neurodegenerative disease of the retina that ultimately results in blindness.